| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0005 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |